EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer | Zendy

Timo Gemoll | Zendy; Sophie Louise Gisela Kollbeck | Zendy; Karl Karstens | Zendy; Gia G. Hò | Zendy; Sonja Hartwig | Zendy; Sarah Strohkamp | Zendy; Katharina Schillo | Zendy; Christoph Thorns | Zendy; Martina Oberländer | Zendy; Kathrin Kalies | Zendy; Stefan Lehr | Zendy; Jens K. Habermann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer

Author(s) -

Timo Gemoll,

Sophie Louise Gisela Kollbeck,

Karl Karstens,

Gia G. Hò,

Sonja Hartwig,

Sarah Strohkamp,

Katharina Schillo,

Christoph Thorns,

Martina Oberländer,

Kathrin Kalies,

Stefan Lehr,

Jens K. Habermann

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.18978

Subject(s) - medicine , colorectal cancer , ulcerative colitis , family medicine , cancer , general surgery , disease

While carcinogenesis in Sporadic Colorectal Cancer (SCC) has been thoroughly studied, less is known about Ulcerative Colitis associated Colorectal Cancer (UCC). This study aimed to identify and validate differentially expressed proteins between clinical samples of SCC and UCC to elucidate new insights of UCC/SCC carcinogenesis and progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research